Jun 19, 2015 02:44 PM EDT
Experimental New Drug Helps Stop Migraines Before They Start
New findings presented at the American Headache Society examine a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies. Research shows that the drugs are promising in the treatment of high-frequency episodic migraines and chronic migraines.
